Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

UROFOLLITROPIN vs VADADUSTAT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

UROFOLLITROPIN vs VADADUSTAT: Safety Overview

Metric UROFOLLITROPIN VADADUSTAT
Total FAERS Reports 101 175
Deaths Reported 1 83
Death Rate 1.0% 47.4%
Hospitalizations 84 54
Average Patient Age 32.6 yrs 76.3 yrs
% Female Patients 97.6% 40.2%
FDA Approval Date N/A Mar 27, 2024
Manufacturer N/A Akebia Therapeutics, Inc.
Route N/A ORAL
Marketing Status Discontinued Prescription